Recon: FDA looks to remove ingestible fluoride products from the market; ITeos and GSK halt developing lung cancer therapy
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States